Telemedicine Companies Owner Sentenced in $20M Healthcare Fraud Scheme
The owner, who also owned several telemarketing companies and committed tax evasion of just over $4 million, now faces 14 years in prison.
Articles
Articles
Subscribe today for full access
to all of these articles.
Latest Articles
PacBio and RBI Collaborate on Lab Sequencing Robot
The companies are working together to explore LabDroid’s capacity to automate sample preparation workflows for long-read sequencing systems.
Theranos In Court: Balwani Lawyers Dealt Another Blow
Move to exclude testimony regarding potential patient impact of lab deficiencies as hearsay is dismissed by the court.
New Method Could Lead to an At-Home Test for COVID-19 Antibodies
In clinical training sets, the new test allowed SARS-CoV-2 antibodies to be detected using widely available glucometers.
LumiraDx Gets CE Clearance for Five Different Products
The UK-based diagnostics firm received CE marks for a diabetes test, CHF test, as well as an analyzer, and two COVID-19 tests.
Hospitals Brace for, Seek to Stave Off Medicare Sequestration Cuts
Combined with rising labor costs, COVID-19, and other challenges, stakeholders say the cuts will negatively impact patient care.
Guidance for Healthcare Workers Treating Suspected Cases of Monkeypox
Experts offer advice in a recent commentary article on treating patients who may have monkeypox during the current COVID-19 pandemic.
CMS Issues First Penalties to Hospitals for Price Transparency Violations
Georgia health system hospitals are the first to be penalized for failing to update their websites or reply to agency warning letters.
Leveraging COVID-19 Testing Infrastructure Can Boost Diabetes Screening
A new study suggests that this is a viable idea, particularly in the context of diabetes screening in a Latinx community.
New Company Formed to Help Improve Access to Diagnostics
The creation of Global Access Diagnostics aims to expand affordable access to quality tests around the world.
OIG: Did Labs Do Enough Non-COVID-19 Testing during Pandemic?
The number of non-COVID-19 tests billed to Medicare during the pandemic has decreased compared to the six-month period before COVID-19.
Genomic Biomarker Tests Endorsed for Early Prostate Cancer Management
Revised guidelines from the American Urological Association support limited use of the tests for certain prostate cancer patients.
FDA Re-Opens Door to Pre-Submission Requests for Non-COVID-19 IVD Tests
The move comes shortly after the FDA said it was going to decline some pre-submission requests to focus on pandemic-related diagnostics.
